Emgrast M 250mcg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Sargramostim (250mcg)
Overview Emgrast M 250mcg Injection
Filgrastim 250mcg injection helps prevent infections following chemotherapy. This medication is a growth factor that boosts white blood cell production in the bone marrow, bolstering the body's infection defenses. Administration is by injection from a healthcare professional. Dosage and frequency are determined by your physician, tailored to your treatment and subject to change. Follow your doctor's instructions precisely; incorrect usage or overdosing can lead to severe adverse reactions. Benefits may take weeks or months to appear; discontinue only under your doctor's guidance. Frequent side effects include bone discomfort, low blood pressure, pyrexia, and dyspnea. Injection site pain, redness, or swelling are also common; however, persistent lumps or extensive bruising warrant medical attention. This medication may not provide complete infection protection; report fever, chills, respiratory distress, pharyngitis, or facial/neck swelling immediately. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy or lactation. Reliable contraception for both partners is crucial during treatment to prevent conception.
Uses of Emgrast M 250mcg Injection
Combating Post-Chemotherapy Infections
Major Benefits of Emgrast M 250mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emgrast M 250mcg Injection:
- Bone pain
- Decreased blood pressure
- Fever
- Breathlessness
- Feeling of discomfort
- Vomiting
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Nausea
- Flu-like symptoms
- Rash
- Diarrhea
How to use Emgrast M 250mcg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Emgrast M 250mcg Injection works:
Filgrastim 250mcg injection promotes white blood cell production in the bone marrow, bolstering the body's infection-fighting defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emgrast M 250mcg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Emgrast M 250mcg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Emgrast M 250mcg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Emgrast M 250mcg Injection on driving ability is undetermined. Refrain from operating a vehicle if you encounter any symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Emgrast M 250mcg Injection cautiously, potentially requiring dosage modification. Kidney function should be regularly assessed during treatment; physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Emgrast M 250mcg Injection cautiously, potentially requiring dosage modification. Medical supervision is recommended, including routine liver function assessments during treatment.
What if you forget to take Emgrast M 250mcg Injection :
Should you forget a dose of Emgrast M 250mcg Injection, seek medical advice.
Facts to Know About Emgrast M 250mcg Injection
| Label | Value |
|---|---|
| Chemical Type | GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Granulocyte-macrophage colony-stimulating factor (GM-CSF) |
3,018 People bought this recently